Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
83,070,866
-
Total 13F shares
-
4,876,578
-
Share change
-
+1,007,985
-
Total reported value
-
$11,166,612
-
Put/Call ratio
-
71%
-
Price per share
-
$2.29
-
Number of holders
-
41
-
Value change
-
+$2,464,048
-
Number of buys
-
26
-
Number of sells
-
17
Institutional Holders of Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) as of Q4 2023
As of 31 Dec 2023,
Checkpoint Therapeutics, Inc. - Common Stock, $0.0001 Par Value (CKPT) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,876,578 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, B. Riley Wealth Advisors, Inc., OSAIC HOLDINGS, INC., D. E. Shaw & Co., Inc., PVG ASSET MANAGEMENT CORP, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.